ORAGENICS INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oragenics Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Oragenics Inc Entity Common Stock, Shares Outstanding for the quarter ending August 8, 2024 was 5.58M shares, a 120% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.58M +3.04M +120% Aug 8, 2024 10-Q 2024-08-09
Q1 2024 4.48M +2.46M +121% Mar 26, 2024 10-K 2024-03-29
Q3 2023 2.57M -115M -97.8% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 2.54M -114M -97.8% Aug 10, 2023 10-Q 2023-08-11
Q1 2023 2.02M -114M -98.3% Apr 14, 2023 10-K 2023-04-17
Q3 2022 117M +1.06M +0.91% Nov 4, 2022 10-Q/A 2023-04-14
Q2 2022 116M Aug 8, 2022 10-Q/A 2023-04-14
Q1 2022 116M +757K +0.65% Mar 8, 2022 10-K/A 2022-07-29
Q3 2021 116M +55.4M +90.8% Nov 12, 2021 10-Q 2021-11-15
Q1 2021 116M +69.5M +151% Apr 30, 2021 10-Q 2021-05-03
Q3 2020 61M +14.9M +32.3% Nov 6, 2020 10-Q 2020-11-10
Q2 2020 61M +14.9M +32.3% Aug 7, 2020 10-Q 2020-08-14
Q1 2020 46.1M +12.5K +0.03% Feb 25, 2020 10-K 2020-03-04
Q3 2019 46.1M +16.7M +56.7% Nov 8, 2019 10-Q 2019-11-14
Q2 2019 46.1M +34.3M +290% Aug 12, 2019 10-Q 2019-08-14
Q1 2019 46.1M +40M +658% Mar 25, 2019 10-K 2019-03-29
Q3 2018 29.4M -19.8M -40.3% Nov 13, 2018 10-Q 2018-11-13
Q2 2018 11.8M -37.4M -76% Aug 8, 2018 10-Q 2018-08-13
Q1 2018 6.09M -43.2M -87.6% May 14, 2018 10-Q 2018-05-15
Q4 2017 4.93M -44.3M -90% Feb 10, 2018 10-K 2018-02-16
Q3 2017 49.3M +160K +0.33% Oct 31, 2017 10-Q 2017-10-31
Q2 2017 49.3M +160K +0.33% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 49.3M +9.22M +23% May 11, 2017 10-Q 2017-05-15
Q4 2016 49.3M Feb 10, 2017 10-K 2017-02-27
Q3 2016 49.1M +12.6M +34.6% Nov 1, 2016 10-Q 2016-11-14
Q2 2016 49.1M +12.6M +34.6% Aug 1, 2016 10-Q 2016-08-15
Q1 2016 40.1M +3.88M +10.7% Mar 30, 2016 10-K 2016-03-30
Q3 2015 36.5M +299K +0.83% Nov 6, 2015 10-Q 2015-11-06
Q2 2015 36.5M +299K +0.83% Aug 7, 2015 10-Q 2015-08-07
Q1 2015 36.2M +50K +0.14% Feb 26, 2015 10-K 2015-02-27
Q3 2014 36.2M +5.67M +18.6% Nov 3, 2014 10-Q 2014-11-03
Q2 2014 36.2M +8.66M +31.5% Aug 5, 2014 10-Q 2014-08-07
Q1 2014 36.1M +8.64M +31.4% Feb 26, 2014 10-K 2014-02-28
Q3 2013 30.5M +3.12M +11.4% Oct 25, 2013 10-Q 2013-10-25
Q2 2013 27.5M +309K +1.14% Aug 9, 2013 10-Q 2013-08-12
Q1 2013 27.5M +15.3M +126% Mar 22, 2013 10-K 2013-03-26
Q3 2012 27.4M +21.6M +372% Nov 1, 2012 10-Q 2012-11-14
Q2 2012 27.2M +21.5M +379% Aug 6, 2012 10-Q 2012-08-10
Q1 2012 12.2M Mar 31, 2012 10-K 2012-04-16
Q3 2011 5.8M Oct 31, 2011 10-Q 2011-11-14
Q2 2011 5.68M Jul 31, 2011 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.